广告
加载中

年销百万单的珂莱诗:靠韦雪带货走红 号称法式品牌实为华人操盘 曾因身体乳宣传“抗炎

蓝鲸 2026-07-13 11:05
蓝鲸 2026/07/13 11:05

邦小白快读

EN
全文速览

本文曝光了网红洗护品牌珂莱诗的真实背景,梳理了该品牌的发展和存在问题,核心干货如下:

1. 品牌真相:珂莱诗对外号称是1989年创立于法国巴黎的法式香氛品牌,实际是华人老板张珂嘉先在国内成立运营公司,八个月后才到巴黎注册空壳公司反向包装的“假洋牌”,所有洗护产品均为国内生产灌装,仅声称原料进口。

2. 发家路径:珂莱诗主打“法式高级感”,用伪体香、约会小心机、奢侈平替等概念迎合年轻人需求,靠头部网红韦雪带货快速起量,三年做到累计销量超488万件、销售额超1亿元,常年占据电商畅销榜。

3. 现存问题:曾因宣传“抗炎”医疗用语违反广告法被罚,目前流量红利消退,销量较巅峰期跌去过半,还存在消费者投诉过敏、售后不足等问题,正面临市场信任考验。

珂莱诗的发展案例能给国内新锐洗护品牌提供营销参考和风险警示,核心干货如下:

1. 可借鉴的经验:珂莱诗抓住当下年轻消费者的需求,把产品和社交属性绑定,用“法式高级感”“奢侈平替”的定位切入,定价60-200元匹配大众消费能力,靠头部达人直播带货快速起量,三年做到年销过亿,这套打法符合当前洗护赛道的消费趋势。

2. 需要警惕的风险:虚假包装品牌血统属于不实宣传,会引发信任危机和舆情,宣传违规使用医疗用语会违反法规受到处罚,要重视品牌宣传的合规性。

3. 经营警示:过度依赖单个头部达人的流量,红利消退后销量直接腰斩,品牌需要提前搭建多元流量渠道,分散经营风险,长期发展需要建立真实的品牌信任,不能只靠营销包装。

珂莱诗的案例给洗护赛道的卖家提供了机会参考和风险提示,核心干货如下:

1. 市场机会:当前香氛洗护赛道增长空间大,消费者愿意为具备社交属性的产品买单,主打轻奢平替、概念营销+达人带货的模式可以快速起量,珂莱诗的成功验证了这个模式的可行性,当线上流量增长见顶时,拓展下沉市场实体门店是新的增量方向,卖家可以参考这个路径布局。

2. 政策与风险提示:化妆品宣传有明确法规要求,绝对不能使用抗炎等医疗用语,也不能虚假宣传品牌背景,否则会被监管处罚,还会引发消费者信任危机,对品牌造成不可逆的伤害。

3. 经营提示:不要过度依赖单个头部达人的流量,珂莱诗近45%的达人销售额来自韦雪,流量红利消退后销量跌去过半,卖家要提前布局自播、私域等自有流量渠道,分散流量风险,保证业绩稳定。

珂莱诗的发展给国内洗护生产工厂带来了产品方向和商业机会的启发,核心干货如下:

1. 产品生产设计方向:当前消费者对香氛洗护的需求越来越高,愿意为高端调香、有概念卖点的产品支付溢价,珂莱诗绑定国际知名调香师,打出“国际奢牌同源”的卖点大获成功,工厂在开发产品时可以匹配这类需求,对接优质调香资源,提升产品的溢价空间。

2. 商业机会:新锐网红洗护品牌的崛起速度快,代加工需求旺盛,珂莱诗全系列洗护产品都是国内惠州的代工厂生产,说明国内工厂完全有能力承接新锐品牌的大规模订单,工厂可以针对性优化产能,对接新锐品牌的代加工需求,拓展业务增量。

3. 转型启示:新锐品牌大多依托电商社交渠道起量,需求变化快、翻单快,工厂可以加快数字化转型,适配小单快反的灵活生产模式,更好匹配新锐品牌的发展需求,提升自身竞争力。

珂莱诗的案例反映了新锐美妆洗护行业的痛点和趋势,给相关服务商带来很多参考,核心干货如下:

1. 行业发展趋势:当下新锐洗护品牌普遍走“概念营销+达人带货”的轻资产发展路径,很多品牌为了提升品牌调性,会选择包装海外背景,整体行业增长快,但合规和经营问题突出,给服务商带来很多业务机会。

2. 客户核心痛点:大部分新锐品牌的创始人合规意识不足,容易在宣传环节踩红线,出现违规使用医疗用语、虚假宣传品牌背景的问题,同时很多品牌过度依赖达人流量,没有稳定的自有流量体系,流量一旦下滑业绩就会暴跌。

3. 解决方案方向:服务商可以针对性开发品牌合规咨询服务,帮助品牌梳理宣传内容,规避合规风险,还可以推出新锐品牌流量运营服务,帮助品牌搭建自播、私域等多渠道流量矩阵,分散流量风险,助力品牌长期稳定发展。

珂莱诗的案例给电商平台的招商、运营管理带来很多启示,核心干货如下:

1. 招商准入环节:要加强对宣称海外血统品牌的资质审核,核查品牌的成立时间、运营主体真实信息,避免虚假包装背景的品牌进入平台,防止误导消费者,影响平台的信任度。

2. 运营管理环节:要加强对平台内品牌宣传内容的巡检,及时清理违规使用医疗用语、虚假宣传品牌历史的内容,督促品牌更新合规的品牌介绍,降低平台的合规风险。

3. 风险规避与服务:针对网红品牌过度依赖达人流量、业绩波动大的问题,平台可以引导品牌开展平台自播,帮助品牌搭建自有流量池,同时可以定期给品牌开展广告法合规培训,提升品牌的合规意识,减少违规问题的发生,优化平台的经营环境。

珂莱诗作为新锐网红洗护品牌的典型案例,对产业研究具备较高的样本价值,核心干货如下:

1. 产业新动向:当前国内新锐美妆洗护产业出现了新的商业模式,很多品牌采用轻资产运营,通过“概念营销+头部达人带货”的模式可以在两三年时间做到年销过亿,还出现了先成立国内运营公司,再到海外注册空壳公司包装高端血统的反向品牌包装操作,迎合了国内部分消费者对海外背景品牌的偏好。

2. 暴露的新问题:行业普遍存在合规风险,不少品牌宣传游走在广告法红线边缘,过度依赖头部达人的商业模式稳定性极差,流量红利消退后业绩容易出现腰斩式下滑,虚假包装也会消耗消费者信任,不利于行业长期发展。

3. 研究启示:该案例反映出当前新锐美妆行业监管存在一定漏洞,后续可以围绕新锐品牌营销合规、流量依赖型商业模式的可持续性开展进一步研究,为完善行业监管规范、推动产业良性发展提供政策建议。

返回默认

声明:快读内容全程由AI生成,请注意甄别信息。如您发现问题,请发送邮件至 run@ebrun.com 。

我是 品牌商 卖家 工厂 服务商 平台商 研究者 帮我再读一遍。

Quick Summary

This article exposes the true background of viral Chinese personal care brand Cellexa, and outlines its development trajectory and current challenges:

1. Brand Reality: Marketed as a French fragrance brand founded in Paris in 1989, Cellexa is actually a "fake foreign brand" reverse-packaged by Chinese owner Zhang Kejia: Zhang first established an operating company in China, then registered an empty shell company in Paris eight months later for branding purposes. All of its personal care products are manufactured and bottled domestically in China, with only claimed imported raw materials.

2. Growth Story: Positioned around a "French luxury aesthetic", Cellexa caters to young consumers with concepts such as "subtle body fragrance", "date night hacks" and "affordable luxury alternatives". It scaled rapidly via influencer marketing led by top Chinese influencer Xue Wei, reaching cumulative sales of over 4.88 million units and more than RMB 100 million in total revenue within three years, and has consistently ranked among top-selling products on Chinese e-commerce platforms.

3. Current Challenges: Cellexa was previously fined for violating China’s Advertising Law by using the medical claim "anti-inflammatory". Following the end of its influencer traffic dividend, its sales have dropped by more than 50% from peak. It also faces consumer complaints over allergic reactions and inadequate after-sales service, and is now facing a crisis of consumer trust.

The Cellexa case offers valuable marketing lessons and risk warnings for emerging Chinese personal care brands:

1. Key Takeaways: Cellexa successfully tapped into demand from young consumers by tying its products to social shareability, positioning itself as a "French luxury" "affordable luxury alternative" priced between RMB 60 and 200 to fit mass consumer budgets. It scaled rapidly via top influencer live-stream marketing, hitting over RMB 100 million in annual revenue within three years. This strategy aligns with current consumer trends in the personal care sector.

2. Key Risks to Avoid: Falsifying brand origin constitutes misleading marketing that can trigger trust crises and public backlash. Using unauthorized medical terms in marketing also violates regulations and leads to penalties. Brands must prioritize compliance in all promotional content.

3. Operational Warning: Over-reliance on traffic from a single top influencer leads to a 50% sales drop once the traffic dividend fades. Brands need to build diversified traffic channels early to spread operational risk, and must build genuine consumer trust for long-term growth instead of relying solely on marketing packaging.

The Cellexa case provides opportunity references and risk alerts for sellers in the personal care sector:

1. Market Opportunities: The scented personal care segment currently offers large growth headroom, as consumers are willing to pay for products with strong social appeal. The model of "affordable luxury positioning + concept marketing + influencer collaboration" can deliver rapid scale, and Cellexa’s success validates this model’s viability. As online traffic growth plateaus, expanding into brick-and-mortar stores in lower-tier markets represents a new growth avenue, which sellers can reference for their own expansion strategies.

2. Regulatory and Risk Alerts: Cosmetics marketing is subject to clear regulatory rules: brands must never use medical claims such as "anti-inflammatory", nor falsify brand background. Violations lead to regulatory penalties, erode consumer trust, and cause irreversible damage to a brand.

3. Operational Guidance: Sellers should avoid over-reliance on a single top influencer: nearly 45% of Cellexa’s influencer-driven sales came from Wei Xue, and sales dropped by more than half after the traffic dividend faded. Sellers should build in-house traffic channels such as brand live streaming and private social domains early to diversify traffic risk and stabilize revenue.

Cellexa’s growth offers insights into product development and new business opportunities for domestic Chinese personal care manufacturers:

1. Product Design Direction: Consumer demand for scented personal care is rising, and shoppers are willing to pay a premium for products with high-end fragrances and compelling selling points. Cellexa achieved success by partnering with internationally renowned perfumers and marketing its products as "sharing the same origin as international luxury brands". Manufacturers can align new product development with this demand, partner with high-quality fragrance resources, and increase product profit margins.

2. New Business Opportunities: Emerging influencer-led personal care brands grow very quickly and have strong demand for contract manufacturing. All of Cellexa’s product line is manufactured by a contract factory in Huizhou, China, proving that domestic factories are fully capable of handling large-scale orders from emerging brands. Factories can optimize their production capacity specifically to serve the OEM needs of emerging brands and grow their business.

3. Transformation Insights: Most emerging brands scale via social e-commerce channels, with rapidly shifting demand and fast repeat orders. Factories can accelerate digital transformation to adapt to a small-batch, fast-turnaround flexible production model, better match the development needs of emerging brands, and improve their own competitiveness.

The Cellexa case reveals key pain points and trends in the emerging beauty and personal care industry, offering valuable insights for relevant service providers:

1. Industry Trends: Most emerging personal care brands currently follow an asset-light growth path of "concept marketing + influencer marketing". Many brands choose to package themselves with foreign origin to boost perceived brand positioning. The overall industry is growing fast, but faces widespread compliance and operational challenges, creating abundant business opportunities for service providers.

2. Core Client Pain Points: Most founders of emerging brands lack compliance awareness, and often cross regulatory lines in marketing: common violations include unauthorized use of medical terms and falsified brand background. In addition, many brands rely excessively on influencer traffic and lack a stable in-house traffic system, leading to severe revenue drops once influencer traffic declines.

3. Solution Opportunities: Service providers can develop targeted brand compliance consulting services to help brands review promotional content and avoid compliance risks. They can also offer specialized traffic operation services for emerging brands, helping brands build a multi-channel traffic matrix including in-house live streaming and private domains, diversify traffic risk, and support long-term stable growth.

The Cellexa case offers key insights for merchant acquisition and operational management for e-commerce platforms:

1. Merchant Onboarding: Platforms should strengthen due diligence for brands claiming foreign origin, verifying founding dates and the true information of operating entities to prevent brands with falsified backgrounds from entering the platform, avoid misleading consumers, and protect platform trust.

2. Operational Management: Platforms should strengthen regular audits of promotional content from onboarded brands, promptly remove content that uses unauthorized medical terms or falsifies brand history, and require brands to update compliant brand introductions to reduce the platform’s own compliance risk.

3. Risk Mitigation and Support: To address the problem of over-reliance on influencer traffic and volatile performance among influencer-led brands, platforms can guide brands to launch in-platform brand live streaming and help them build owned traffic pools. Platforms can also hold regular Advertising Law compliance training for brands to improve compliance awareness, reduce violations, and optimize the platform’s overall operating environment.

As a representative case of emerging influencer-led personal care brands, Cellexa offers high sample value for industry research:

1. New Industry Dynamics: A new business model has emerged in China’s emerging beauty and personal care industry: many brands operate with an asset-light model, and can reach over RMB 100 million in annual revenue within two to three years via "concept marketing + top influencer marketing". A new reverse branding practice has also appeared: founders first establish a domestic operating company, then register an empty shell company overseas to package the brand as a high-end foreign origin brand, catering to the preference of some Chinese consumers for foreign-branded products.

2. Exposed New Problems: Widespread compliance risks exist across the industry, with many brands’ marketing activities walking the line of China’s Advertising Law. The business model of over-reliance on top influencers is extremely unstable: performance tends to plummet by 50% or more once the traffic dividend fades. Falsified brand origin also erodes consumer trust, harming the long-term development of the entire industry.

3. Research Implications: This case reveals existing regulatory gaps in the emerging beauty industry. Future research can focus on marketing compliance for emerging brands and the sustainability of traffic-dependent business models, to provide policy recommendations for improving industry regulatory standards and promoting the healthy development of the sector.

Disclaimer: The "Quick Summary" content is entirely generated by AI. Please exercise discretion when interpreting the information. For issues or corrections, please email run@ebrun.com .

I am a Brand Seller Factory Service Provider Marketplace Seller Researcher Read it again.

蓝鲸新闻7月9日讯(记者 陆鹏鹏 汤诗韵)一家披着法式外衣的洗护品牌CLINSIS珂莱诗,仅用三年便做到销量超过480万单、沐浴露单品销量超过200万单、销售额超过1亿元,常年占据电商平台多个畅销榜。

然而,蓝鲸记者调查发现,所谓的法式血统不过是营销包装,背后实为华人操盘。

年销量百万,销售额过亿

法式品牌珂莱诗曾号称创立于1989年

从官方目前的定位看,珂莱诗是一家“法式香氛生活美学品牌”,主营沐浴露、身体乳、香氛喷雾、面霜等个人护理产品,定价集中在60元至200元区间。

电商平台公开数据显示,其品牌店铺粉丝数已达53.7万,产品累计销量超过488万件。其中,爆款法式香氛沐浴露单链接已售出超200万单,好评率93.9%。该单品定价62元,保守估算累计销售额已达1.24亿元。除了沐浴露外,香氛喷雾、护手霜等产品同样有数十万的销量。

此外,在多个电商平台上,珂莱诗的产品常年在畅销榜名列前茅。品牌披露,北京吾德市场研究有限公司依2025年4月-2026年3月的数据统计分析得到,CLINSIS为法式香氛沐浴露全国销量第一。

支撑起这些销量的,是一套高度本土化、紧扣社交需求的“法式”营销话术。

在电商直播间和社交媒体上,珂莱诗的内容传播始终绑定“法式”高级感标签,以“伪体香”“约会小心机”“富家千金香”“度假香”等概念切入,营造强烈的社交价值感,并以“奢侈平替”的定位迎合年轻消费者对轻奢的想象。

值得注意的是,就在2025年,该品牌仍在官网等官方渠道大肆宣传一段颇有历史厚度的故事:宣称CLINSIS创立于1989年的法国巴黎,在法国拥有200余家终端网点,零售网络覆盖全球超10000家门店,广泛入驻高端SPA馆、沙龙理发店和皮肤管理中心。

即便现在,网络上不少未被清理的宣传软文仍保留着这些说法。

然而,上述“品牌历史”如今在官方渠道已全部消失,品牌介绍悄然更换为“法式香氛生活美学品牌”“法国香氛设计师定制沙龙香氛生活品牌”等更为含糊的表述。

品牌在产品详情和推广资料中提及的调香师Véronique Nyberg、Emilie Coppermann等人的确是国际知名的大师。公开资料显示,前述两位调香师合作品牌包括Burberry、Givenchy、KARL LAGERFELD、Jimmy Choo等。因此在相关宣传中,CLINSIS强调其“汇聚全球顶尖调香师”、“国际奢牌香水同源”。

珂莱诗的“法式血统”真相

先有中国公司,再赴巴黎注册,同一华人老板操盘

然而,这个处处标榜“法式”血统的品牌,究竟是不是真正的法国品牌?其宣传过的历史底蕴又是否经得起推敲?

蓝鲸记者以消费者身份向商家咨询,商家介绍称,面霜、沐浴、精粹露等产品“都有进口的”。当记者追问具体产地时,客服解释:“护肤线的产品是法国原装进口的,洗护类的产品原料法国进口,国内灌装的。”

客服随后展示了其中一款产品的包装。包装信息显示,法国公司为“CLINSIS SALON SARL”,地址为“8,rue du Faubourg Poissonniere,75010 Paris France”。

记者随即核查发现,法国境内曾先后存在两家同名的“CLINSIS SALON SARL”公司,且法定代表人均为同一人“Kejia Zhang”。

第一家公司的注册办公地,正是产品包装上印着的“8 rue du Faubourg Poissonnière,75010 Paris”。然而,这家公司成立于2023年2月21日,距今仅三年多,注册资金仅有100欧元。值得注意的是,这家公司已于2025年6月30日正式注销。

公司注销后不到四个月,2025年10月31日,一家全新的同名公司“CLINSIS SALON SARL”再次注册成立,法定代表人依然是Kejia Zhang,但办公地址已变更为“200 rue de la Croix Nivert,75015 Paris”,注册资本则从此前的100欧元升至5000欧元。

法国公司的真相逐渐浮出水面,国内运营实体又是谁?

记者查看产品备案信息发现,珂莱诗产品在国内的备案及实际运营公司为“上海珂莱诗品牌管理有限公司”。目前其有75条化妆品备案信息,均为洗护产品。而这些产品的生产企业均为惠州兆婷化妆品有限公司,生产地址位于广东惠州。

天眼查数据显示,上海珂莱诗品牌管理有限公司成立于2022年7月25日,法定代表人张珂嘉,注册资本100万元人民币,主营业务为日用百货销售。股权结构上,张珂嘉持股99%,为公司实际控制人。

一个关键的时间线至此清晰,上海珂莱诗品牌管理有限公司成立于2022年7月,而第一家法国“CLINSIS SALON SARL”公司直到2023年2月才注册。这意味着,国内运营主体比所谓的“法国品牌方”早诞生了整整八个月。品牌宣称的“法式”血统,从一开始便是一场先有中国公司、再赴巴黎注册壳公司的反向包装。

更值得关注的是,两家法国公司的法定代表人“Kejia Zhang”与国内公司的法定代表人“张珂嘉”,实名信息完全吻合。也就是说,从巴黎到上海,从品牌包装到日常运营,珂莱诗从头至尾由同一名华人老板一手操盘。

海外销售渠道方面,蓝鲸记者未能在亚马逊上搜索到CLINSIS相关产品。不过其在Shopee等网站上确有部分链接,大多评价较少。

目前CLINSIS有一个英文官网,但该网站上并无关于品牌历史的介绍,点进产品页面也无任何具体信息,详情部分内容显示为空白。

曾宣传“抗炎”医疗用语被罚

因达人带货走红、流量红利正逐渐消退

天眼查显示,2025年2月7日,珂莱诗曾因产品宣传“抗炎”医疗用语被罚。

处罚决定书显示,上海珂莱诗品牌管理有限公司行为违反了《中华人民共和国化妆品监督管理条例》第四十三条第二款“化妆品广告不得明示或者暗示产品具有医疗作用,不得含有虚假或者引人误解的内容,不得欺骗、误导消费者。”及《中华人民共和国广告法》第十七条“除医疗、药品、医疗器械广告外,禁止其他任何广告涉及疾病治疗功能,并不得使用医疗用语或者易使推销的商品与药品、医疗器械相混淆的用语。”的规定。

综合考量违法行为的情节和危害后果,决定作出从轻处罚款1200元。

其实市场上去年就已经有了质疑珂莱诗法国血统的声音。黑猫投诉平台上,有消费者反馈称使用产品后过敏、存在售后问题等。像每一个快速走红的品牌一样,珂莱诗势必也要面临市场与大众的长期考验。

蓝鲸记者查询发现,珂莱诗产品自2023年7月逐渐起量,达人在品牌推广初期起到了较大作用,当年CLINSIS单平台近9成的销售额来自达人推广。以头部达人直播为跳板实现一鸣惊人,是当下新锐美妆品牌的惯用手法,CLINSIS正是“达人造神”的收益者之一。

其爆发发生在2024年10月,新晋“美妆一姐”韦雪凭借“清醒大女人”人设迅速走红,直播月销售额破亿。在当时,韦雪金句“选男人和选香就没输过”流传一时,而韦雪曾带货十余款珂莱诗产品。第三方数据平台显示,以某头部电商平台为例,2024年韦雪带货CLINSIS的GMV占到品牌达人销售额的近45%,CLINSIS品牌的月销售额随后长期稳定在千万以上。

不过从第三方平台的数据来看,CLINSIS品牌近几个月的月销量约在10-25w,较巅峰期的50-100w已跌去过半。珂莱诗的流量红利正在消退。

或为寻找更多增量,这个法式品牌目前已拓展至部分下沉市场的实体门店。蓝鲸记者浏览发现,多个地方城市的美妆集合店、供应商也开始推荐CLINSIS的产品。

针对本轮舆情,珂莱诗官方目前尚未发布声明,其产品仍正常在售。但对于一个想要长期发展的品牌而言,因此引发的市场审视是一道绕不开的难题。

注:文/蓝鲸,文章来源:蓝鲸新闻(公众号ID:lanjingcj),本文为作者独立观点,不代表亿邦动力立场。

文章来源:蓝鲸新闻

广告
微信
朋友圈

FAQ回顾

珂莱诗是真正的法国品牌吗?

珂莱诗并非真正的法国品牌,其国内运营主体上海珂莱诗品牌管理有限公司2022年7月成立,比2023年2月注册的法国同名壳公司早8个月,两家公司法定代表人均为华人张珂嘉,全程由华人操盘。

珂莱诗为什么曾被行政处罚?

2025年2月,珂莱诗因在产品宣传中使用“抗炎”等医疗用语,违反《中华人民共和国化妆品监督管理条例》《中华人民共和国广告法》相关规定,被从轻处以1200元罚款。

珂莱诗的销量表现怎么样?

珂莱诗产品累计销量超488万件,爆款法式香氛沐浴露单链接售出超200万单,累计销售额约1.24亿元;靠达人韦雪带货走红,巅峰期月销50-100万单,目前月销已跌去过半。

珂莱诗主营哪些产品,定价如何?

珂莱诗定位法式香氛生活美学品牌,主营沐浴露、身体乳、香氛喷雾、面霜等个人护理产品,定价集中在60元至200元区间,洗护类产品多为法国进口原料国内灌装。

这么好看,分享一下?

朋友圈 分享

APP内打开

赞 +1
+1
微信好友 朋友圈 新浪微博 QQ空间
关闭
收藏成功
发送
/140 0